Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WCG Acquires eClinical Provider VeraSci | Contract Pharma

What are you searching for?

Sign in
Breaking News

WCG Acquires eClinical Provider VeraSci

Aims to address growing demand for scientific and technology solutions for remote data capture, hybrid virtual studies and decentralized clinical trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WCG has acquired VeraSci, a global provider of specialty scientific expertise and eClinical software to support clinical trials focused on central nervous system (CNS) disorders. VeraSci, based in Durham, NC, expands WCG’s scientific and patient engagement capabilities, and complements its CNS offerings, including those available via the Company’s MedAvante, ProPhase and Analgesic Solutions businesses. With this acquisition, WCG aims to address the growing demand for scientific and technology solutions for remote data capture, hybrid virtual studies and fully decentralized clinical trials in key CNS therapeutic areas.
 
VeraSci provides clients with innovative solutions that aim to improve data quality in clinical trials, including endpoint and assessment services, rater training and certification, language and translation support, and eCOA and ePRO technologies. With its Pathway technology platform, which can be configured to meet the needs of any study across the globe, VeraSci is designed to enable the collection of high-quality data that can be used to assess symptoms, cognition and functional capacity in a wide range of therapeutic indications.

“WCG’s acquisition of VeraSci represents a natural next step and an exciting growth opportunity,” said Donald A. Deieso, Ph.D., Executive Chairman and CEO of WCG. “On behalf of WCG, I’m proud to welcome VeraSci, an organization that shares our dedication to improving the clinical trial experience for patients and sites, commitment to scientific rigor and passion for bringing novel technologies into clinical trial processes. This is a marriage of two premier global teams with a common vision.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics